Analysis of the genetic factors in the clinical polymorphism of endogenous functional psychoses
Gindilis, V.M.; Shakhmatova-Pavlova, I.V.
Vestnik Akademii Meditsinskikh Nauk SSSR 7: 14-23
1979
ISSN/ISBN: 0002-3027 PMID: 539090 Document Number: 151401
Document emailed within 1 workday
Related Documents
Panteleeva, G.P.; Artiukh, V.V.; Kopeĭko, G.I.; Bologov, P.V.; Nikiforova, I.I.; Shchekal, K.E. 2011: Clinical-genetic parameters and the nosological evaluation of schizoaffective psychosis in systematics of attack-like endogenous psychoses Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(4): 12-21Golimbet, V.E.; Kaleda, V.G.; Alfimova, M.V.; Korovaĭtseva, G.I.; Lavrushina, O.M.; Barkhatova, A.N.; Kasparov, S.V.; Ivanova, N.V. 2007: The molecular-genetic study of juvenile endogenous attack-like psychoses Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 107(8): 49-54
Golimbet, V.E.; Trubnikov, V.I. 1997: Molecular genetic testing in endogenous psychoses: the outlook for its use from the viewpoint of medical ethics Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 97(10): 74-75
Iacoviello, L.; Donati, M.B. 1999: Genetic polymorphism of coagulation factors as a cardiovascular risk factor Minerva Cardioangiologica 47(11): 401-402
Guerra, A.; Rego, C.; Castro, E.M.; Sinde, S.; Silva, D.; Rodrigues, P.; Crespo, M.E.; Albergaria, F.; Bicho, M. 2000: Acid phosphatase, genetic polymorphism and cardiovascular risk factors in a pediatric population Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 19(6): 679-691
Vega, M.A.; Bragado, R.; Iványi, P.; Peláez, J.L.; López de Castro, J.A. 1986: Molecular analysis of a functional subtype of HLA-B27. a possible evolutionary pathway for HLA-B27 polymorphism Journal of Immunology 137(11): 3557-3565
Zerbin-Rüdin, E. 1979: Genetics of endogenous psychoses Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 125(2): 287-299
Dayer, P.; Courvoisier, F.; Kupfer, A.; Balant-Gorgia, A.; Balant, L.; Fabre, J. 1983: Pharmacokinetic and clinical consequences of the genetic polymorphism of oxidation Schweizerische Medizinische Wochenschrift 113(8): 295-297
Edeki, T. 1996: Clinical importance of genetic polymorphism of drug oxidation Mount Sinai Journal of Medicine new York 63(5-6): 291-300
Gerbaldo, H.; Bochnik, H.J. 1987: Contribution to the classification of endogenous psychoses Acta Psiquiatrica y Psicologica de America Latina 33(1): 71-73
Heinz, G.; Tölle, R. 1976: The driving ability following the endogenous psychoses Medizinische Klinik 71(3): 128-130
Weitbrecht, H.J. 1961: Endogenous phasic psychoses. Symptomatology and course Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 29: 129-144
Dvoráková, M.; Májský, A.; Zvolský, P. 1989: Incidence of HLA-DR antigens in endogenous psychoses Ceskoslovenska Psychiatrie 85(4): 217-222
Vovin, R.Ia.; Gurevich, Z.P.; Skorik, A.I.; Zatonskaia, M.S.; Kiunnapu, I.V. 1980: Intensive therapy of endogenous psychoses Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 80(6): 909-914
Weitbrecht, H.J. 1974: Psychopathology of suicide in endogenous psychoses Die Medizinische Welt 25(24): 1059-1064
Dadali, E.L.; Illarioshkin, S.N.; Markova, E.D.; Ivanova-Smolenskaia, I.A. 1992: Clinical polymorphism and genetic heterogeneity of hereditary spastic ataxia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(4): 10-13
Flores, D.L.; Alvarado, I.; Wong, M-Li.; Licinio, J.; Flockhart, D. 2004: Clinical implications of genetic polymorphism of CYP2D6 in Mexican Americans Annals of Internal Medicine 140(11): W71
Furet, Y.; Bechtel, Y.; Le Guellec, C.; Bechtel, P.R.; Autret-Leca, E.; Paintaud, G. 2002: Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism Therapie 57(5): 427-431
Blankenburg, W. 1970: On the structure of achievement in chronic endogenous psychoses Der Nervenarzt 41(12): 577-587
Von der Mühlen, H. 1972: "Imagined" pregnancy as a hallucination in endogenous psychoses Der Nervenarzt 43(6): 314-317